- Home
- FPAY vs CVKD Comparison
FPAY vs CVKD Comparison
Compare FPAY & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FPAY
- CVKD
- Stock Information
- Founded
- FPAY 2003
- CVKD 2022
- Country
- FPAY United States
- CVKD United States
- Employees
- FPAY 204
- CVKD N/A
- Industry
- FPAY Diversified Commercial Services
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- FPAY Consumer Discretionary
- CVKD Health Care
- Exchange
- FPAY Nasdaq
- CVKD Nasdaq
- Market Cap
- FPAY 27.2M
- CVKD 29.5M
- IPO Year
- FPAY N/A
- CVKD 2023
- Fundamental
- Price
- FPAY $1.10
- CVKD $12.95
- Analyst Decision
- FPAY Strong Buy
- CVKD Strong Buy
- Analyst Count
- FPAY 2
- CVKD 1
- Target Price
- FPAY $3.25
- CVKD $32.00
- AVG Volume (30 Days)
- FPAY 83.2K
- CVKD 35.0K
- Earning Date
- FPAY 08-05-2025
- CVKD 08-06-2025
- Dividend Yield
- FPAY N/A
- CVKD N/A
- EPS Growth
- FPAY N/A
- CVKD N/A
- EPS
- FPAY N/A
- CVKD N/A
- Revenue
- FPAY $139,800,732.00
- CVKD N/A
- Revenue This Year
- FPAY $16.58
- CVKD N/A
- Revenue Next Year
- FPAY N/A
- CVKD N/A
- P/E Ratio
- FPAY N/A
- CVKD N/A
- Revenue Growth
- FPAY 19.51
- CVKD N/A
- 52 Week Low
- FPAY $0.84
- CVKD $5.70
- 52 Week High
- FPAY $2.37
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- FPAY 43.10
- CVKD 49.98
- Support Level
- FPAY $0.84
- CVKD $11.00
- Resistance Level
- FPAY $1.17
- CVKD $13.56
- Average True Range (ATR)
- FPAY 0.09
- CVKD 1.15
- MACD
- FPAY -0.01
- CVKD 0.25
- Stochastic Oscillator
- FPAY 58.70
- CVKD 80.97
About FPAY FlexShopper Inc.
FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.